BIO Professional Development
Through a curated network of education alliance partners, BIO offers industry professionals executive training and development resources for accelerating career growth
06/15/2025 - 06/15/2025 | 12:30 PM - 4:30 PM EDT
Commercialization Readiness from Preclinical to 1st Launch: The First Time CEOs Playbook
Commercialization Readiness from Preclinical to 1st Launch: The First Time CEOs Playbook will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meet critical Commercial and Medical Affairs milestones.
The drug development process is complex and multifaceted, and understanding the commercialization considerations at each phase is vital. From preclinical to first product launch, this one-day course will help biotech executives make informed strategic choices for long-term success.
Beginning with Phase I, this interactive course will cover the phase-specific commercialization activities and preparation emerging companies need to make for a successful first launch, including Market analysis with competitive landscape assessment, the Commercialization Roadmap development including launch critical success factors, FTEs and dollar spend required for launch, market access pricing and reimbursement, value proposition development, and go-to-market preparation and regulatory considerations. Note that these early commercial flows inform emerging biotech companies' corporate and partnering strategies.
Russ Belden, founder and CEO of Bridge, will guide you through this course by sharing real-world examples and valuable insights. Russ is a biotech commercialization leader with over 36 years of senior operational experience in the preclinical to 1st launch space and a popular Biotech Primer instructor.
About Biotech Primer:
Biotech Primer is a trusted leader in delivering life sciences training that simplifies complex topics for non-scientists. With over 20 years of experience, industry-specific courses are expertly crafted to provide a clear understanding of the science, business, and regulatory frameworks essential for success in Biotechnology, Pharmaceuticals, Molecular Diagnostics, and Medical Devices. All BIO members receive a 15% discount on all Biotech Primer on-demand courses with the code BIO15.
This half-day course will be held in-person on Sunday afternoon, June 15, 2025, in Boston, Mass. Registration opens on January 27, 2025.
Interested in only registering for an in-person course in Boston? For course-only registration instructions, email: courseshelp@bio.org
Takeaways
- Identify financing success and critical commercial and medical affairs milestones.
- Discover strategic positioning to make informed strategic choices for long-term success, from preclinical stages to the first product launch.
- Gain a comprehensive understanding of phase-specific activities, such as market analysis, value proposition development, pricing, reimbursement, and regulatory considerations.
- Explain how early commercial flows will inform emerging biotech companies’ corporate and partnering strategies.
- Discover key elements that influence successful commercial launches, including target product profiles, revenue forecasting, market research, key hires, branding, and life cycle management.
Certificate Requirements
- Attend the entire in-person course
- Complete course evaluation within two weeks of the course end date
A good regulatory strategy is essential to a good business strategy.
Do we correct information about our drug in a company’s sponsored chat room? What types of websites shouldn’t we link to? Learn the FDA regs and more.
Under what conditions can companies find a safe harbor for communicating investigational data? How and why is scientific exchange codified in the Code of Federal Regulations (CFR). Learn the FDA regs and more.